首页> 外国专利> PERIPHERAL BLOOD TCR MARKER FOR OVARIAN CANCER, AND DETECTION KIT AND USE THEREOF

PERIPHERAL BLOOD TCR MARKER FOR OVARIAN CANCER, AND DETECTION KIT AND USE THEREOF

机译:卵巢癌的外周血TCR标记,以及检测套件及其使用

摘要

Provided are a peripheral blood TCR marker for ovarian cancer, and a detection kit and the use thereof. The marker comprises at least one protein from those shown in SEQ ID NOs: 1-100. On the basis of a high-throughput sequencing method, only a small amount of peripheral blood needs to be taken to extract RNA. An immune repertoire library is established by means of processing samples. Then, by means of high-throughput sequencing and TCR data analysis, a characteristic TCR sequence in the peripheral blood for ovarian cancer is first determined, and then test results of samples to be tested are compared with the characteristic TCR sequence, so as to determine whether one has ovarian cancer. By means of the method, a large number of specific TCR sequences of ovarian cancer can be simultaneously compared, and the method has higher specificity and accuracy compared with the separate detection of one or more markers, thereby improving the diagnostic efficiency.
机译:提供用于卵巢癌的外周血TCR标记,以及检测套件及其用途。 标记物包含来自SEQ ID NO:1-100中所示的至少一种蛋白质。 在高通量测序方法的基础上,仅需要采取少量外周血以提取RNA。 通过处理样品建立免疫力曲目库。 然后,通过高通量测序和TCR数据分析,首先确定用于卵巢癌的外周血中的特征TCR序列,然后将要测试的样品的测试结果与特征TCR序列进行比较,以确定 是否有卵巢癌。 借助于该方法,比较大量的卵巢癌的特异性TCR序列,与一个或多个标记的单独检测相比,该方法具有更高的特异性和准确性,从而提高了诊断效率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号